{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:03:11Z","timestamp":1772136191502,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011495","name":"Massachusetts Life Sciences Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011495","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020385","name":"Sullivan Family Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020385","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Point-of-care antigen-detecting rapid diagnostic tests (RDTs) to detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) represent a scalable tool for surveillance of active SARS-CoV-2 infections in the population. Data on the performance of these tests in real-world community settings are paramount to guide their implementation to combat the COVID-19 pandemic. We evaluated the performance characteristics of the CareStart COVID-19 Antigen test (CareStart) in a community testing site in Holyoke, Massachusetts. We compared CareStart to a SARS-CoV-2 reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) reference, both using anterior nasal swab samples. We calculated the sensitivity, specificity, and the expected positive and negative predictive values at different SARS-CoV-2 prevalence estimates. We performed 666 total tests on 591 unique individuals. 573 (86%) were asymptomatic. There were 52 positive tests by RT-qPCR. The sensitivity of CareStart was 49.0% (95% Confidence Interval (CI) 34.8\u201363.4) and specificity was 99.5% (95% CI 98.5\u201399.9). Among positive RT-qPCR tests, the median cycle threshold (Ct) was significantly lower in samples that tested positive on CareStart. Using a Ct\u2009\u2264\u200930 as a benchmark for positivity increased the sensitivity of the test to 64.9% (95% CI 47.5\u201379.8). Our study shows that CareStart has a high specificity and moderate sensitivity. The utility of RDTs, such as CareStart, in mass implementation should prioritize use cases in which a higher specificity is more important, such as triage tests to rule-in active infections in community surveillance programs.<\/jats:p>","DOI":"10.1038\/s41598-022-25266-3","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T08:07:24Z","timestamp":1670573244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of the Access Bio CareStart rapid SARS-CoV-2 antigen test in asymptomatic individuals tested at a community mass-testing program in Western Massachusetts"],"prefix":"10.1038","volume":"12","author":[{"given":"Sara","family":"Suliman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfredo R.","family":"Matias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel R.","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco J.","family":"Molano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Uceta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan M.","family":"Paxton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean F.","family":"Gonsalves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maegan V.","family":"Harden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Meldrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly F.","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah T.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra C.","family":"Smole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence C.","family":"Madoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise C.","family":"Ivers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"5","key":"25266_CR1","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1473-3099(20)30120-1","volume":"20","author":"E Dong","year":"2020","unstructured":"Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect. Dis. 20(5), 533\u2013534. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"9","key":"25266_CR2","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"K Liu","year":"2020","unstructured":"Liu, K. et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin. Med. J. (Engl.) 133(9), 1025\u20131031. https:\/\/doi.org\/10.1097\/CM9.0000000000000744 (2020).","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"6","key":"25266_CR3","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41591-020-0891-7","volume":"26","author":"K Ramdas","year":"2020","unstructured":"Ramdas, K., Darzi, A. & Jain, S. \u2018Test, re-test, re-test\u2019: Using inaccurate tests to greatly increase the accuracy of COVID-19 testing. Nat. Med. 26(6), 810\u2013811. https:\/\/doi.org\/10.1038\/s41591-020-0891-7 (2020).","journal-title":"Nat. Med."},{"key":"25266_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2020.11.002","author":"MM Hellou","year":"2020","unstructured":"Hellou, M. M. et al. Nucleic-acid-amplification tests from respiratory samples for the diagnosis of coronavirus infections: Systematic review and meta-analysis. Clin. Microbiol. Infect. https:\/\/doi.org\/10.1016\/j.cmi.2020.11.002 (2020).","journal-title":"Clin. Microbiol. Infect."},{"key":"25266_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30766-0","author":"RCH Brown","year":"2020","unstructured":"Brown, R. C. H., Kelly, D., Wilkinson, D. & Savulescu, J. The scientific and ethical feasibility of immunity passports. Lancet Infect. Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30766-0 (2020).","journal-title":"Lancet Infect. Dis."},{"issue":"5","key":"25266_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7326\/M20-3012","volume":"173","author":"DP Oran","year":"2020","unstructured":"Oran, D. P. & Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection\u202f: A narrative review. Ann. Intern. Med. 173(5), 362\u2013367. https:\/\/doi.org\/10.7326\/M20-3012 (2020).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"25266_CR7","doi-asserted-by":"publisher","first-page":"e175","DOI":"10.1016\/S2468-2667(20)30308-X","volume":"6","author":"BJ Quilty","year":"2021","unstructured":"Quilty, B. J. et al. Quarantine and testing strategies in contact tracing for SARS-CoV-2: A modelling study. Lancet Public Health 6(3), e175\u2013e183. https:\/\/doi.org\/10.1016\/S2468-2667(20)30308-X (2021).","journal-title":"Lancet Public Health"},{"issue":"5152","key":"25266_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.15585\/mmwr.mm695152a3","volume":"69","author":"IW Pray","year":"2021","unstructured":"Pray, I. W. et al. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses\u2014Wisconsin, September\u2013October 2020. MMWR Morb. Mortal. Wkly. Rep. 69(5152), 1642\u20131647 (2021).","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"16","key":"25266_CR9","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1001\/jama.2020.4169","volume":"323","author":"J Hopman","year":"2020","unstructured":"Hopman, J., Allegranzi, B. & Mehtar, S. Managing COVID-19 in low- and middle-income countries. JAMA 323(16), 1549\u20131550. https:\/\/doi.org\/10.1001\/jama.2020.4169 (2020).","journal-title":"JAMA"},{"key":"25266_CR10","unstructured":"WHO. Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim Guidance. (2020). 11 September 2020. Accessed online: https:\/\/www.who.int\/publications\/i\/item\/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays"},{"key":"25266_CR11","doi-asserted-by":"publisher","first-page":"013705","DOI":"10.1002\/14651858.CD013705.pub2","volume":"3","author":"J Dinnes","year":"2021","unstructured":"Dinnes, J. et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst. Rev. 3, 013705. https:\/\/doi.org\/10.1002\/14651858.CD013705.pub2 (2021).","journal-title":"Cochrane Database Syst. Rev."},{"key":"25266_CR12","unstructured":"FDA. In Vitro Diagnostics EUAs. U S Food and Drug Administration. (2021). Published online March 8, 2021. https:\/\/www.fda.gov\/medical-devices\/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices\/vitro-diagnostics-euas. Accessed 9 March 2021."},{"key":"25266_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02338-20","author":"S Young","year":"2020","unstructured":"Young, S. et al. Clinical evaluation of BD Veritor SARS-CoV-2 point-of-care test performance compared to PCR-based testing and versus the Sofia 2 SARS Antigen point-of-care test. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.02338-20 (2020).","journal-title":"J. Clin. Microbiol."},{"key":"25266_CR14","doi-asserted-by":"publisher","first-page":"104789","DOI":"10.1016\/j.jcv.2021.104789","volume":"137","author":"ET Landaas","year":"2021","unstructured":"Landaas, E. T. et al. Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort. J. Clin. Virol. 137, 104789. https:\/\/doi.org\/10.1016\/j.jcv.2021.104789 (2021).","journal-title":"J. Clin. Virol."},{"key":"25266_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00083-21","author":"NR Pollock","year":"2021","unstructured":"Pollock, N. R. et al. Performance and implementation evaluation of the Abbott BinaxNOW rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.00083-21 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"25266_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa802","author":"G Pilarowski","year":"2021","unstructured":"Pilarowski, G. et al. Performance characteristics of a rapid SARS-CoV-2 antigen detection assay at a public plaza testing site in San Francisco. J Infect Dis. https:\/\/doi.org\/10.1093\/infdis\/jiaa802 (2021).","journal-title":"J Infect Dis."},{"key":"25266_CR17","doi-asserted-by":"publisher","unstructured":"Pollock, N. R., Tran, K., Jacobs, J. R., Cranston, A. E., Smith, S., O\u2019Kane, C. Y., Roady, T. J., Moran, M., Scarry, A., Carroll, M., Volinsky, L., Perez, G., Patel, P., Gabriel, S., Lennon, N. J., Madoff, L. C., Brown, C. & Smole, S. C. Performance and operational evaluation of the Access Bio CareStart rapid antigen test in a high-throughput drive-through community testing site in Massachusetts. MedRxiv. (2021). Pre-print: https:\/\/doi.org\/10.1101\/2021.03.07.21253101v1.full-text. Accessed 5 April 2021.","DOI":"10.1101\/2021.03.07.21253101v1.full-text"},{"key":"25266_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/2021.03.19.21253964","author":"RL Smith","year":"2021","unstructured":"Smith, R. L. et al. Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection. medRxiv https:\/\/doi.org\/10.1101\/2021.03.19.21253964 (2021).","journal-title":"medRxiv"},{"key":"25266_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00260-21","author":"A Kilic","year":"2021","unstructured":"Kilic, A., Hiestand, B. & Palavecino, E. Evaluation of performance of the BD Veritor SARS-CoV-2 chromatographic immunoassay test in COVID-19 symptomatic patients. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.00260-21 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"25266_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.03282-20","author":"NC Okoye","year":"2021","unstructured":"Okoye, N. C. et al. Performance characteristics of BinaxNOW COVID-19 antigen card for screening asymptomatic individuals in a university setting. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.03282-20 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"25266_CR21","unstructured":"FDA. Coronavirus (COVID-19) Update: FDA Continues to Advance Over-the Counter and Other Screening Test Development. U S Food and Drug Administration. (2021). Press Release, Published online: March 31, 2021."},{"key":"25266_CR22","unstructured":"Healthcare T. Stop the Spread testing sites (2022). https:\/\/www.transformativehccom\/stop-the-spread\/. Accessed 27 Sept 2022."},{"key":"25266_CR23","unstructured":"Epidemiologists CCoSaT. Update to the standardized surveillance case definition and national notification for 2019 novel coronavirus disease (COVID-19). Infectious Disease Committee. (2020). Accessed online: https:\/\/cdn.ymaws.com\/www.cste.org\/resource\/resmgr\/ps\/positionstatement2020\/Interim-20-ID-02_COVID-19.pdf"},{"key":"25266_CR24","unstructured":"Clinical Research Sequencing Platform (CRSP) LatBIoMaH. CRSP SARS-CoV-2 Real-time Reverse Transcriptase (RT)-PCR Diagnostic Assay. https:\/\/www.fdagov\/media\/139858\/download"},{"key":"25266_CR25","unstructured":"FDA. Emergency Use Authorization (EUA) Summary: CRSP SARS-CoV-2 Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Assay. (2022). https:\/\/www.fda.gov\/media\/146499\/download. Accessed 28 Sept 2022"},{"key":"25266_CR26","unstructured":"Diagnostics A. CareStart COVID-19 Antigen: Rapid Diagnostic Test for the Detection of SARS-CoV-2 Antigen (2020). Accessed online: https:\/\/www.accessbiodiagnosticsnet\/wp-content\/uploads\/2021\/02\/EUA-accessbio-CareStart-Antigen-ifupdf. Instructions for Use Under Emergency Use Authorization."},{"key":"25266_CR27","doi-asserted-by":"crossref","unstructured":"Jaafar, R., Aherfi, S., Wurtz, N., Grimaldier, C., Hoang, T. V., Colson, P., Raoult, D. & La Scola, B. Correlation Between 3790 Quantitative Polymerase Chain Reaction\u2013Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates. Clinical Infectious Diseases. (2020). Correspondence.","DOI":"10.1093\/cid\/ciaa1491"},{"issue":"9","key":"25266_CR28","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.cgh.2017.05.002","volume":"15","author":"R Hernaez","year":"2017","unstructured":"Hernaez, R. & Thrift, A. P. High negative predictive value, low prevalence, and spectrum effect: Caution in the interpretation. Clin. Gastroenterol. Hepatol. 15(9), 1355\u20131358. https:\/\/doi.org\/10.1016\/j.cgh.2017.05.002 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"25266_CR29","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1002\/jmv.26673","volume":"93","author":"K Syal","year":"2021","unstructured":"Syal, K. Guidelines on newly identified limitations of diagnostic tools for COVID-19 and consequences. J. Med. Virol. 93(4), 1837\u20131842. https:\/\/doi.org\/10.1002\/jmv.26673 (2021).","journal-title":"J. Med. Virol."},{"issue":"2","key":"25266_CR30","doi-asserted-by":"publisher","first-page":"e2037067","DOI":"10.1001\/jamanetworkopen.2020.37067","volume":"4","author":"S Dryden-Peterson","year":"2021","unstructured":"Dryden-Peterson, S. et al. Disparities in SARS-CoV-2 testing in Massachusetts during the COVID-19 pandemic. JAMA Netw. Open 4(2), e2037067. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.37067 (2021).","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"25266_CR31","doi-asserted-by":"publisher","first-page":"e0241536","DOI":"10.1371\/journal.pone.0241536","volume":"15","author":"M Yanes-Lane","year":"2020","unstructured":"Yanes-Lane, M. et al. Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: A systematic review and meta-analysis. PLoS ONE 15(11), e0241536. https:\/\/doi.org\/10.1371\/journal.pone.0241536 (2020).","journal-title":"PLoS ONE"},{"key":"25266_CR32","doi-asserted-by":"publisher","first-page":"104781","DOI":"10.1016\/j.jcv.2021.104781","volume":"137","author":"F Perez-Garcia","year":"2021","unstructured":"Perez-Garcia, F. et al. Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection. J. Clin. Virol. 137, 104781. https:\/\/doi.org\/10.1016\/j.jcv.2021.104781 (2021).","journal-title":"J. Clin. Virol."},{"key":"25266_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa638","author":"J Bullard","year":"2020","unstructured":"Bullard, J. et al. Predicting infectious SARS-CoV-2 from diagnostic samples. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa638 (2020).","journal-title":"Clin. Infect. Dis."},{"issue":"8","key":"25266_CR34","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1093\/cid\/ciaa1249.PubMedPMID:33029620;PMCID:PMC7499497","volume":"72","author":"C Rhee","year":"2021","unstructured":"Rhee, C., Kanjilal, S., Baker, M. & Klompas, M. Duration of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) infectivity: When is it safe to discontinue isolation?. Clin. Infect. Dis. 72(8), 1467\u20131474. https:\/\/doi.org\/10.1093\/cid\/ciaa1249.PubMedPMID:33029620;PMCID:PMC7499497 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"25266_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01316-7","author":"M Levine-Tiefenbrun","year":"2021","unstructured":"Levine-Tiefenbrun, M. et al. Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-021-01316-7 (2021).","journal-title":"Nat. Med."},{"key":"25266_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00425-6","author":"MJ Mina","year":"2021","unstructured":"Mina, M. J., Peto, T. E., Garcia-Finana, M., Semple, M. G. & Buchan, I. E. Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(21)00425-6 (2021).","journal-title":"Lancet"},{"issue":"6","key":"25266_CR37","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/infdis\/jiab337.PubMedPMID:34191025;PMCID:PMC8448437","volume":"224","author":"RL Smith","year":"2021","unstructured":"Smith, R. L. et al. Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection. J. Infect. Dis. 224(6), 976\u2013982. https:\/\/doi.org\/10.1093\/infdis\/jiab337.PubMedPMID:34191025;PMCID:PMC8448437 (2021).","journal-title":"J. Infect. Dis."},{"issue":"7","key":"25266_CR38","doi-asserted-by":"publisher","first-page":"e0254559","DOI":"10.1371\/journal.pone.0254559","volume":"16","author":"Y Zhou","year":"2021","unstructured":"Zhou, Y. & O\u2019Leary, T. J. Relative sensitivity of anterior nares and nasopharyngeal swabs for initial detection of SARS-CoV-2 in ambulatory patients: Rapid review and meta-analysis. PLoS ONE 16(7), e0254559. https:\/\/doi.org\/10.1371\/journal.pone.0254559 (2021).","journal-title":"PLoS ONE"},{"key":"25266_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02881-20","author":"RA Lee","year":"2021","unstructured":"Lee, R. A., Herigon, J. C., Benedetti, A., Pollock, N. R. & Denkinger, C. M. Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: A systematic review and meta-analysis. J. Clin. Microbiol. https:\/\/doi.org\/10.1128\/JCM.02881-20 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"25266_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2022.08.05.22278466","author":"A Soni","year":"2022","unstructured":"Soni, A. et al. Performance of screening for SARS-CoV-2 using rapid antigen tests to detect incidence of symptomatic and asymptomatic SARS-CoV-2 infection: Findings from the Test Us at Home prospective cohort study. medRxiv https:\/\/doi.org\/10.1101\/2022.08.05.22278466 (2022).","journal-title":"medRxiv"},{"issue":"1","key":"25266_CR41","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1186\/s12879-021-06257-7","volume":"21","author":"BA Trombetta","year":"2021","unstructured":"Trombetta, B. A. et al. Evaluation of serological lateral flow assays for severe acute respiratory syndrome coronavirus-2. BMC Infect. Dis. 21(1), 580. https:\/\/doi.org\/10.1186\/s12879-021-06257-7 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"25266_CR42","doi-asserted-by":"publisher","first-page":"100583","DOI":"10.1016\/j.xcrm.2022.100583","volume":"3","author":"R Earnest","year":"2022","unstructured":"Earnest, R. et al. Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA. Cell Rep. Med. 3(4), 100583. https:\/\/doi.org\/10.1016\/j.xcrm.2022.100583 (2022).","journal-title":"Cell Rep. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25266-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25266-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T18:06:15Z","timestamp":1670868375000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25266-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25266"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25266-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.17.21259109","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"14 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21338"}}